The recent surge in funding into boutique pharmaceutical companies, particularly those focusing on groundbreaking therapies and challenging drug development programs, has fueled what some are calling "High Roller https://lawsondpwc288158.alltdesign.com/elite-roller-pharma-the-speculative-wager-58850230